Phase 4 Chronic Kidney Disease Trial, Recruiting (NCT04381143)

Phase 4 Chronic Kidney Disease Trial, Recruiting NCT04381143 Sponsor: Guangdong Provincial People's Hospital Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04381143 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and currently on dialysis (either newly started or already established on dialysis).
You are expected to need ongoing, long-term dialysis treatment.
You are willing and able to give your consent to take part in this study.

Who may not be able to join:

Your doctor has decided you need to take blood-thinning or anti-clotting medications (such as aspirin, warfarin, or similar medicines).
Your doctor has determined that aspirin is not safe for you for any reason.
You are on dialysis due to a sudden, short-term kidney problem where your kidneys are expected to recover.
You have had a bleeding stroke or bleeding inside your brain within the last 12 months.
You have a condition that affects your blood's ability to clot normally, for any reason.
You are unable to give your own consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Xueqing Yu, Guangdong Provincial People's Hospital

Phone: +86-20-83827812

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04381143

Sponsor: Guangdong Provincial People's Hospital

Phase: Phase 4

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +86-20-83827812

More information: https://clinicaltrials.gov/study/NCT04381143

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and currently on dialysis (either newly started or already established on dialysis).
You are expected to need ongoing, long-term dialysis treatment.
You are willing and able to give your consent to take part in this study.

Who may not be able to join:

Your doctor has decided you need to take blood-thinning or anti-clotting medications (such as aspirin, warfarin, or similar medicines).
Your doctor has determined that aspirin is not safe for you for any reason.
You are on dialysis due to a sudden, short-term kidney problem where your kidneys are expected to recover.
You have had a bleeding stroke or bleeding inside your brain within the last 12 months.
You have a condition that affects your blood's ability to clot normally, for any reason.
You are unable to give your own consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Guangdong Provincial People's Hospital

Registry

ClinicalTrials.gov

Start date

30 July 2020

Est. completion

1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of Participants with composite of major cardiovascular events (3-point MACE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov